Approaches to reducing animal numbers in vaccine potency testing

Procedia in Vaccinology

Volumn 5, Issue , 2011, Pages 227-231

  Kulpa Eddy, Jodie ^a   Srinivas, Geetha ^a  

^a UNITED STATES DEPARTMENT OF AGRICULTURE   (United States)

Author keywords

Alternatives; Vaccine potency test

Indexed keywords

RABIES VACCINE; TUBERCULIN; VACCINE;

ANIMAL RIGHTS; ANIMAL TESTING REDUCTION; ARTICLE; DOSE RESPONSE; DRUG POTENCY; DRUG SURVEILLANCE PROGRAM; EXPERIMENTAL DESIGN; EXPERIMENTAL GUINEA PIG; GOVERNMENT REGULATION; INJECTION SITE REACTION; NONHUMAN; PRIORITY JOURNAL; SKIN TEST; VACCINE PRODUCTION; VETERINARY MEDICINE;

EID: 84555191809     PISSN: None     EISSN: 1877282X     Source Type: Journal    
DOI: 10.1016/j.provac.2011.10.023     Document Type: Article

References (17)

1. Viruses, Serum, Toxins, Antitoxins, and Analogous Products Act of 1913. Public Law 430 (and Public Law 99-198, 1985 amendments), 21 U.S.C. 151-159 et. seq. Available at: http://www.aphis.usda.gov/animal_health/vet_biologics/publications/vsta.pdf.
2. U.S. Code of Federal Regulations. 9 CFR 101-123. Title 9-Animals and Animal Products; Chapter 1-Animal and Plant Health Inspection Service, Department of Agriculture; Subchapter E-Viruses, Serums, Toxins, and Analogous Products: Organisms and Vectors; Parts 101 to 123. Available at: http://www.aphis.usda.gov/animal_health/vet_biologics/vb_cfr.shtml.
3. ICCVAM (Interagency Coordinating Committee on the Validation of Alternative Methods) Authorization Act of 2000. Public Law 106-545, 42 U.S.C. 285l-2 et. seq. Available at: http://iccvam.niehs.nih.gov/docs/about_docs/PL106545.pdf.
4. Russell WMS, Burch RL. The Principles of Humane Experimental Technique. London, Methuen, 1959. Available at: http://altweb.jhsph.edu/pubs/books/humane_exp/het-toc.
5. Weisser K, Hechler U. (1997). Animal Welfare Aspects in the Quality Control of Immunobiologicals. A Critical Evaluation of Animal Tests in Pharmacopoeial Monographs. Nottingham, UK, Fund for the Replacement of Animals in Medical Experiments (FRAME) for ECVAM and the Paul-Ehrlich-Institut, 1997: 146. Available at: http://www.frame.org.uk/dynamic_files/immuno_chapter_8.pdf.
6. U.S. Department of Agriculture, Center for Veterinary Biologics. Supplemental Assay Method for the Evaluation of Tuberculin Purified Protein Derivative (PPD) (SAM 636). Ames (IA), USDA, 2007. Available at: http://www.aphis.usda.gov/animal_health/vet_biologics/publications/636.pdf.
7. World Organisation for Animal Health (OIE). Manual of Diagnostic Tests and Vaccines for Terrestrial Animals 2010. Vol. 2. Paris, OIE, 2010: 10-12. Available at: http://www.oie.int/fr/normes-internationales/manuel-terrestre/acces-en-ligne/.
8. U.S. Department of Agriculture, Center for Veterinary Biologics. Supplemental Assay Method for Potency Testing of Inactivated Rabies Vaccine in Mice Using the National Institutes of Health Test (SAM 308). Ames (IA), USDA, 2007. Available at: http://www.aphis.usda.gov/animal_health/vet_biologics/publications/308.pdf.
9. Wilbur LA, Aubert MFA. The NIH test for potency. In: Meslin FX, Kaplan MM, Koprowski H, editors. Laboratory Techniques in Rabies, 4th ed. Geneva, World Health Organization, 1996: Chapter 37.
10. Bruckner L, Cussler K, Halder M, Barrat J, Castle P, Duchow K, Gatewood DM, Gilbert R, Groen J, Knapp B, Levis R, Milne C, Parker S, Stünkel K, Visser N, Volkers P. Three Rs approaches in the quality control of inactivated rabies vaccines. The report and recommendations of ECVAM Workshop 48. Altern Lab Anim 2003; 31(4):429-54. Available at: http://ecvam.jrc.it/publication/ECVAM%20Workshop%2048.pdf.
11. World Health Organization. Recommendations for inactivated rabies vaccine for human use produced in cell substrates and embryonated eggs. In: WHO Expert Committee on Biological Standardization. Fifty-sixth Report. Geneva, World Health Organization, 2007: 107-10, Annex 2 (WHO Technical Report Series, No. 941). Available at: http://whqlibdoc.who.int/trs/WHO_TRS_941.pdf.
12. ICCVAM/NICEATM. Report on the ICCVAM-NICEATM/ECVAM Scientific Workshop on Alternative Methods to Refine, Reduce or Replace the Mouse LD50 assay for Botulinum Toxin Testing. NIH Publication No. 08-6416. Research Triangle Park (NC), National Institute of Environmental Health Sciences, 2008. Available at: http://iccvam.niehs.nih.gov/docs/biologics-docs/BoNTwkshprept.pdf.
13. International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Products (VICH). What is VICH? - Definition, history and objectives [Internet]. Brussels (Belgium), VICH. Available at: http://www.vichsec.org/en/what-is.htm.
14. International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH). Target Animal Safety: Examination of Live Veterinary Vaccines in Target Animals for Absence of Reversion to Virulence (VICH GL 41). Brussels (Belgium), VICH, 2007. Available at: http://www.vichsec.org/en/guidelines2.htm.
15. International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH). Target Animal Safety for Veterinary Live and Inactivated Vaccines (VICH GL 44). Brussels (Belgium), VICH, 2008. Available at: http://www.vichsec.org/en/guidelines2.htm.
16. U.S. Department of Agriculture, Center for Veterinary Biologics. Veterinary Services Memorandum 800.201. General Licensing Considerations: Backpassage Studies. Washington, DC, Animal and Plant Health Inspection Service (APHIS), 2008. Available at: http://www.aphis.usda.gov/animal_health/vet_biologics/publications/memo_800_201.pdf.
17. U.S. Department of Agriculture, Center for Veterinary Biologics. Veterinary Services Memorandum 800.207. General Licensing Considerations: Target Animal Safety (TAS) Studies Prior to Product Licensure - VICH Guideline 44. Washington, DC, Animal and Plant Health Inspection Service (APHIS), 2010. Available at: http://www.aphis.usda.gov/animal_health/vet_biologics/publications/memo_800_207.pdf.